Macleods Pharmaceuticals Ltd — Kit Exporter Profile
Indian Pharmaceutical Exporter · #4 for Kit · $1.8M export value · DGFT Verified
Macleods Pharmaceuticals Ltd is the #4 Indian exporter of Kit with $1.8M in export value and 36 verified shipments. Macleods Pharmaceuticals Ltd holds a 0.4% market share in Kit exports across 7 countries.
Macleods Pharmaceuticals Ltd — Kit Export Profile: Buyers & Destinations
Where Does Macleods Pharmaceuticals Ltd Export Kit?
| Country | Value | Shipments | Share |
|---|---|---|---|
| NIGERIA | $600.0K | 12 | 30.5% |
| KENYA | $450.0K | 9 | 22.9% |
| ETHIOPIA | $350.0K | 8 | 17.8% |
| PAPUA NEW GUINEA | $250.0K | 5 | 12.7% |
| GHANA | $150.0K | 3 | 7.6% |
| DJIBOUTI | $150.0K | 3 | 7.6% |
| MALDIVES | $12.2K | 1 | 0.6% |
| MARSHALL ISLANDS | $6.9K | 1 | 0.4% |
Macleods Pharmaceuticals Ltd exports Kit to 8 countries. The largest destination is NIGERIA accounting for 30.5% of Macleods Pharmaceuticals Ltd's Kit shipments, followed by KENYA (22.9%) and ETHIOPIA (17.8%). These destinations reflect Macleods Pharmaceuticals Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Kit from Macleods Pharmaceuticals Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| NATIONAL TUBERCULOSIS AND LEPROSY | NIGERIA | $600.0K | 12 |
| KENYA MEDICAL SUPPLIES AGENCY | KENYA | $450.0K | 9 |
| NATIONAL DEPARTMENT OF HEALTH | PAPUA NEW GUINEA | $200.0K | 4 |
| MINISTRY OF HEALTH | GHANA | $100.0K | 2 |
| ETHIOPIAN PHARMACEUTICALS SUPPLY A | ETHIOPIA | $100.0K | 3 |
| ETHIOPIAN PHARMACEUTICAL SUPPLY AG | ETHIOPIA | $100.0K | 2 |
| DIRECTOR OF PROCUREMENT AND SUPPLY | GHANA | $50.0K | 1 |
| NATIONAL DEP OF HEALTH | PAPUA NEW GUINEA | $50.0K | 1 |
| DIRECTOR GENERAL OF PUBLIC HEALTH | MALDIVES | $12.2K | 1 |
| MINISTRY OF HEALTH AND HUMAN SERVIC | MARSHALL ISLANDS | $6.9K | 1 |
Macleods Pharmaceuticals Ltd supplies Kit to 10 buyers globally. The largest buyer is NATIONAL TUBERCULOSIS AND LEPROSY (NIGERIA), followed by KENYA MEDICAL SUPPLIES AGENCY (KENYA) and NATIONAL DEPARTMENT OF HEALTH (PAPUA NEW GUINEA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Kit Export Value and How Much Does Macleods Pharmaceuticals Ltd Contribute?
India exported $57.8M worth of Kit through 15,000 shipments from 1048 suppliers to 191 countries, serving 3,293 buyers globally. Macleods Pharmaceuticals Ltd contributes $1.8M to this total, accounting for 0.4% of India's Kit exports. Macleods Pharmaceuticals Ltd ships Kit to 8 countries through 10 buyers.
What Is the Average Shipment Value for Macleods Pharmaceuticals Ltd's Kit Exports?
Macleods Pharmaceuticals Ltd's average Kit shipment value is $50.0K per consignment, based on 36 shipments totaling $1.8M. The largest destination is NIGERIA (30.5% of Macleods Pharmaceuticals Ltd's Kit exports).
How Does Macleods Pharmaceuticals Ltd Compare to Other Indian Kit Exporters?
Macleods Pharmaceuticals Ltd ranks #4 among 1048 Indian Kit exporters with a 0.4% market share. The top 3 exporters are SANDOZ PRIVATE LIMITED ($7.8M), MERIL DIAGNOSTICS PRIVATE LIMITED ($5.6M), MICRO LABS LIMITED ($5.5M). Macleods Pharmaceuticals Ltd processed 36 shipments to 7 destination countries.
What Kit Formulations Does Macleods Pharmaceuticals Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| TB KIT CAT I & III KIT A(STOP TB KIT)6 B | $312.2K | 7 |
| TB KIT CAT I & III KIT A (STOP TB KIT) 6 | $206.9K | 5 |
| PATIENT PACK KIT RHZE(RIFAMPICIN 150MG+I | $150.0K | 3 |
| PATIENT KIT(FORECOX TRAC) (RIFAMPICIN 150MG+ISONIAZID 75MG+PYRAZINAMIDE 400MG+ETHAMBUTOL 275MG TABLETS USP)NOS | $150.0K | 3 |
| TB KIT CAT I&III KIT A(STOP TB KIT) 12X14?S 4FDC(R150/H75/Z400/E275)& 12X28?S 2FDC(R150/H75) BNO.NCPA2401TONCPA2405(1000 | $150.0K | 3 |
| TB KIT CAT I&III KIT A(STOP TB KIT) 12X14?S 4FDC(R150/H75/Z400/E275)& 12X28?S 2FDC(R150/H75) BNO.NRH2403A&NRH2404A | $150.0K | 3 |
| TB KIT CAT I&III KIT A(STOP TB KIT) 12X14?S 4FDC(R150/H75/Z400/E275)& 12X28?S 2FDC(R150/H75) BNO.NRH2404ATONRH2408A | $150.0K | 3 |
| MEDICINES. RIFAMPICIN 150MG+ISONIAZID 75MG TABLETS,BP PATIENT KIT (PART OF PATIENT KITS)RH-COM | $100.0K | 2 |
| TB KIT CAT I & III KIT A(STOP TB KIT) 6 | $50.0K | 1 |
| TB KIT CAT I III KIT A STOP TB KIT 6 BLISTER WITH 28 TABLETS EACH OF 4 FDC R150 H75 Z400 E275 8333 PACK | $50.0K | 1 |
Macleods Pharmaceuticals Ltd exports 21 distinct Kit formulations including tablets, capsules, syrups, and combination drugs. The top formulation is TB KIT CAT I & III KIT A(STOP TB KIT)6 B with 7 shipments worth $312.2K.
Regulatory Requirements: Exporting Kit to Key Markets
What Macleods Pharmaceuticals Ltd must comply with to export Kit to its top destination countries
Nigeria — NAFDAC
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Macleods Pharmaceuticals Ltd Compare to Nearest Kit Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 15 | ALKEM LABORATORIES LIMITED | $2.1M | 67 | 2 | $31.0K |
| 11 | AFROWAY PHARMA | $1.9M | 37 | 4 | $50.0K |
| 4 | MACLEODS PHARMACEUTICALS LTD ★ | $1.8M | 36 | 7 | $50.0K |
Macleods Pharmaceuticals Ltd ranks #4 among 1048 Indian Kit exporters. Average shipment value of $50.0K compared to the market average of $55.1K. The closest competitors by value are ALKEM LABORATORIES LIMITED and AFROWAY PHARMA.
Which Indian Ports Ship Kit Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 2,763 | 18.4% |
| SAHAR AIR | 2,534 | 16.9% |
| DELHI AIR CARGO ACC (INDEL4) | 1,051 | 7.0% |
| DELHI AIR | 983 | 6.6% |
| NHAVA SHEVA SEA (INNSA1) | 901 | 6.0% |
| Bombay Air | 541 | 3.6% |
| JNPT/ NHAVA SHEVA SEA | 433 | 2.9% |
| CHENNAI AIR CARGO ACC (INMAA4) | 405 | 2.7% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Kit — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Kit shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Macleods Pharmaceuticals Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 42 individual customs records matching Macleods Pharmaceuticals Ltd exporting Kit, covering 21 formulations to 8 countries via 10 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 191+ countries, 3,293+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Kit Export Data from Macleods Pharmaceuticals Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Macleods Pharmaceuticals Ltd's Kit exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Macleods Pharmaceuticals Ltd
Company Profile
0 products · $0 total trade · 0 categories
Kit Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Macleods Pharmaceuticals Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Kit. For current shipment-level data, contact TransData Nexus.